Abstract: The present invention relates to a pharmaceutical composition containing Kaempferia parviflora Wall. Ex. Baker extracts for treating muscle diseases, and more specifically to a pharmaceutical composition containing, as an active ingredient, Kaempferia parviflora Wall. Ex. Baker extracts or flavone compound isolated therefrom for treating muscle diseases or a dietary composition for improving muscle function. Kaempferia parviflora Wall. Ex. Baker extracts or flavone compound isolated therefrom according to the present invention reduces protein catabolism in the muscles and increases muscle cell differentiation and anabolism, and is thus effective for preparing pharmaceutical composition for treating muscle diseases and dietary composition for improving muscle function.

Abstract: The present specification provides a heterocyclic compound, and an organic light emitting device including: a first electrode, a second electrode, and organic material layers formed of one or more layers including a light emitting layer disposed between the first electrode and the second electrode, in which one or more layers of the organic material layers include the heterocyclic compound or a compound in which a heat-curable or photo-curable functional group is introduced into the heterocyclic compound.

Abstract: A color conversion panel includes a substrate, a plurality of color conversion layers and a transmission layer on the substrate, a capping layer on the plurality of color conversion layers and the transmission layer, and a filter layer on the capping layer.

Abstract: A display apparatus includes a display panel including a first subpixel having a first primary color, a second subpixel having a second primary color; and a transparent subpixel; a panel driver which sets grayscale data of the first subpixel, the second subpixel and the transparent subpixel; a light source part which provides light to the display panel, where the light source comprises a first light source and a second light source having colors different from each other; and a light source driver which turns on the first light source during a first subframe, turns on the second light source during a second subframe, and turns on the first light source during a third subframe, and a first frame comprises the first subframe, the second subframe and the third subframe.

Abstract: The present application provides a new nitrogen-containing heterocyclic compound and an organic electronic device using the same.

Abstract: A polymer electrolyte membrane for a fuel cell includes a cross-linking polymer in which a polyhedral oligomeric silsequioxane (POSS) is cross-linked with a hydrocarbon-based polymer and a membrane-electrode assembly for a fuel cell includes the polymer electrolyte membrane.

Abstract: A fuel cell stack includes at least one membrane electrolyte assembly having an electrolyte membrane, an anode on a first surface of the electrolyte membrane, and a cathode on a second surface opposite to the first surface of the electrolyte membrane; and at least one supply member coupled to the electrolyte membrane and configured to supply a conductive material to the electrolyte membrane.

Abstract: A syringe device for skin treatment is provided, which includes a syringe for injecting a drug into a skin through a needled at an end, a syringe seat connected with a cylinder of the syringe receiving the drug therein to allow a reciprocation of the cylinder within a limited range according to a direction of injecting the drug, a mount formed on the syringe seat and to which the cylinder of the syringe is fixed, an injector mounted on one side of the syringe seat to be rotated by a driving force to move in association with movement of the syringe seat to move a rod of the cylinder toward a needle, and a controller mounted on one sides of the syringe seat and the injector to operate the injector when the needle is in contact with the skin and the syringe seat is moved to one end within a limited range, and stop the injector when the needle is apart from the skin and the syringe seat is moved to opposite end within the limited range.

Abstract: An electrode catalyst for a fuel cell, an electrode, a fuel cell, and a membrane electrode assembly (MEA), the electrode catalyst including a carbonaceous support, and a catalyst metal loaded on the carbonaceous support, wherein the carbonaceous support includes a functional group bound on a surface thereof, the functional group being represented by one of Formula 1 or Formula 2, below,

Abstract: A display device includes a display member and a backlight unit, where the display member includes a base substrate, a cover layer that is on the base substrate, extends in a first direction, and includes a plurality of portions defining a first cavity and a second cavity that are spaced apart from the base substrate and adjacent to each other in the first direction, a first display element and a second display element that respectively correspond to the first cavity and the second cavity, a color conversion filter that is disposed on the cover layer, and includes a first filter which overlaps the first cavity and converts incident light into a first color light, and a second filter which overlaps the second cavity and converts incident light into a second color light, and an optical member which is disposed between the color conversion filter and the cover layer.

Abstract: The present specification relates to an organic electronic device in which a new compound, which can improve the life span, the efficiency, the electrochemical stability and the thermal stability of the organic electronic device, is included in an organic material layer.

Abstract: A color conversion panel includes a substrate and a red color conversion layer, a green color conversion layer, and a transmission layer which are disposed on the substrate. The transmission layer includes at least one of a pigment and a dye.

Abstract: A display panel includes: a plurality of pixels; and a first phase shifting layer and a second phase shifting layer, which overlap the pixels, where the first phase shifting layer and at least a portion of the second phase shifting layer are alternately arranged with each other, and a phase difference between light having a predetermined wavelength transmitted through the first phase shifting layer and light having the predetermined wavelength transmitted through the second phase shifting layer is approximately 180 degrees.

Abstract: Provided is a highly sensitive pressure sensor that includes a lower substrate on which a first electrode having surface roughness is formed; an upper substrate on which a second electrode having surface roughness is formed; and a dielectric material stacked between the lower substrate and the upper substrate to be disposed between the first electrode and the second electrode.

Abstract: A display device having a first substrate, a second substrate above and facing the first substrate, a light-amount adjusting layer interposed between the first substrate and the second substrate, a plurality of color conversion layers respectively defining a plurality of pixel regions, a wavelength conversion layer disposed on a bottom surface of the color conversion layers, and a backlight unit disposed under the first substrate. The light-amount adjusting layer comprises liquid crystal molecules.

Abstract: A photosensitive resin composition according to an exemplary embodiment of the present invention includes: a nanophosphor; a photo-polymerization initiator including an acetophenone-based initiator; and a photo-polymerization compound, wherein the photo-polymerization initiator further includes at least one among a thioxanthone-based initiator, an oxime-based initiator, and a benzophenone-based initiator.

Abstract: Aspects according to one or more embodiments of the present invention are directed toward a quantum dot sheet, and a light unit and a liquid crystal display including the same, having desirable features of being capable of increasing light efficiency. According to exemplary embodiments of the present invention, it is possible to increase light efficiency by forming a quantum dot sheet including quantum dots in a pattern in which multiple layers having different refractive indexes are repeatedly stacked.

Abstract: The present invention relates to a new use of capsiate or dihydrocapsiate, more particularly to a composition for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease or for suppressing immunity comprising capsiate, dihydrocapsiate or a pharmaceutically acceptable salt thereof as an effective ingredient. The composition and immunosuppressant of the present invention may be used for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease, and for suppressing immunity.

Abstract: A display apparatus includes a light source configured to generate lights having a plurality of colors, the light source configured to be driven in a field sequential color driving method; and a display panel configured to receive the lights to display an image, display the colors at a first area in a first order, and display the colors at a second area different from the first area in a second order different from the first order.

Abstract: The present invention provides an organic light emitting device including a dibenzothiophene-based compound and an organic material layer composed of one more layers including a first electrode, a second electrode and a light emitting layer disposed between the first electrode and the second electrode, in which one or more layers of the organic material layer include the dibenzothiophene-based compound of Formula 1 or a compound in which a heat curable or photo curable functional group is introduced into the dibenzothiophene-based compound.